Table 3.
Efficacy Measures at Baseline and 4-Month Follow-Up
| Baseline Mean (SD) | 4-Month Follow-Up Mean (SD) | Mean Difference (Follow-Up – Baseline), 95% Confidence Interal | p-value | |
|---|---|---|---|---|
| Minutes of MVPA | 8.0 (9.9) | 8.9 (12.1) | 0.78 [−1.6, 3.2] | 0.5145 |
| Minutes of Light Intensity Activity | 272.9 (81.3) | 274.6 (89.7) | −0.63 [−17.3, 16.0] | 0.9392 |
| Sedentary Minutes | 679.0 (85.1) | 676.5 (93.9) | −0.15 [−17.0, 16.7] | 0.9858 |
| Number of Steps | 4392 (2217) | 4571 (2483) | 143.7 [− 174.9, 462.2] | 0.3683 |
| WOMAC Pain | 8.1 (3.6) | 6.2 (3.8) | −1.9 [−2.7, − 1.0] | < 0.0001 |
| WOMAC Function | 26.2 (13.2) | 20.2 (12.5) | −6.1 [− 8.7, − 3.4] | < 0.0001 |
MVPA Moderate to Vigorous Physical Activity
WOMAC Western Ontario and McMaster Universities Osteoarthritis Index; Ranges 0–20 for Pain, 0–68 for Function, higher scores indicate worse symptoms